Pharming Group N.V (PHAR) Leases: 2019-2025
Historic Leases for Pharming Group N.V (PHAR) over the last 5 years, with Sep 2025 value amounting to $17.5 million.
- Pharming Group N.V's Leases fell 20.29% to $17.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.5 million, marking a year-over-year decrease of 20.29%. This contributed to the annual value of $16.4 million for FY2024, which is 31.10% down from last year.
- Latest data reveals that Pharming Group N.V reported Leases of $17.5 million as of Q3 2025, which was up 5.52% from $16.6 million recorded in Q2 2025.
- In the past 5 years, Pharming Group N.V's Leases ranged from a high of $30.4 million in Q1 2023 and a low of $9,067 during Q1 2021.
- In the last 3 years, Pharming Group N.V's Leases had a median value of $22.1 million in 2024 and averaged $22.3 million.
- Within the past 5 years, the most significant YoY rise in Pharming Group N.V's Leases was 214,209.11% (2022), while the steepest drop was 99.92% (2022).
- Pharming Group N.V's Leases (Quarterly) stood at $19.9 million in 2021, then soared by 44.18% to $28.8 million in 2022, then declined by 17.31% to $23.8 million in 2023, then slumped by 31.10% to $16.4 million in 2024, then declined by 20.29% to $17.5 million in 2025.
- Its Leases stands at $17.5 million for Q3 2025, versus $16.6 million for Q2 2025 and $16.5 million for Q1 2025.